Insights
Industry Trends & UpdatesinXso 2021 MedTech Series R&D focal points
For 2021 inXso has created a webinar series outlining some specific features that are essential for global design of medical technology, and introduces some regulatory aspects in context of EU MDR and Swiss regulatory landscape, as well as some basic features from Chinese and Japanese regulations that everyone – or every company – considering these healthcare markets should now of.
How to build internationalization strategy for HealthTech
Internationalization attempts usually fail due to a lack of thorough preparation and adherence to the chosen strategy.
When it comes to the medical industry – such as life sciences, healthcare technology, biomedical technology, and pharmaceuticals – an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.
User-Centered Design of Medical Devices
In recent years, medical technology has taken a trend towards creating personalized care while seeking ways to enhance the quality of healthcare for patients and lower healthcare costs. At the same time, developers must keep in mind the devices’ ease of use and gain regulatory approval in the highly internationalized market.
Capturing user profiles and use environments across nations and cultures needs more creative, wide-reaching, and complex problem-solving approaches than the conventional preference for scientific and technological advancement.
The Internationalization Challenge of Biomedical Innovations
The life science industry distinguishes itself from other high-technology industries with such fundamental dimensions as applying scientific knowledge to provide technological solutions aiming to improve health care and quality of life – in a highly regulated environment. At the same time, usually purchasing decisions are not made by end-consumers, but their physicians or such third party as an insurance company, for example.
Apply for HealthTech Online Pitching
On 22nd May an online pitching for HealthTech Startups is organized by inXso together with Slush China to Venture Capital investors of which there is a significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma and BioMedTech.
What are the Key Points of Chinese Health Tech Initiatives – Join Discussion on May 29th
In our series focusing on Health Tech in Chinese market inXso is organizing an interactive webinar “Health Tech China Focus” together with Tampere HealthHUB that will briefly discuss some of the key points and rather unique aspects of Chinese Health Tech initiatives and their implementation.
WHO DO WE WORK WITH










Office
Biokatu 12, FinnMedi 5
33520 Tampere
Finland